NCT03239015 2022-03-04
Efficacy and Safety of Precision Therapy in Refractory Tumor
Shanghai Changzheng Hospital
Phase 2 Unknown
Clinical Trials
6 trialsNCT02929693 2019-04-11
Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma
Shanghai University of Traditional Chinese Medicine
Phase 3 Unknown
NCT02142036 2019-03-13
MetAction
Oslo University Hospital
Phase 2 Completed
NCT00177242 2016-01-18
Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma
University of Pittsburgh
Phase 2 Completed
NCT00127829 2009-04-23
AGUS
AstraZeneca
Phase 1 Completed
NCT00635973 2009-04-22
Open-Label Extension of Other SZ1839 (Iressa) Trials
AstraZeneca
Phase 3 Completed